Pharmacological analysis of doxorubicin in genetically engineered human iPS cell-derived cardiomyocytes

被引：0
|
作者：
Hayashi, Erina [1 ]
Fujizuka, Miki [1 ]
Furukawa, Tetsushi [1 ]
Kurokawa, Junko [1 ]
机构：
[1] Tokyo Med Dent Univ, MRI, Dept Bioinform Pharmacol, Tokyo, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2015年 / 128卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P1-83
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [21] Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
    Ge, Feixiang
    Wang, Zetian
    Xi, Jianzhong Jeff
    CELLS, 2020, 9 (01)
  • [22] Maturation of human embryonic stem cell-derived cardiomyocytes in engineered heart tissue
    Tiburcy, Malte
    Rogge, Christina
    Rahmat, Siti
    Zweigerdt, Robert
    Gagliardi, Mark
    Keller, Gordon
    Boettger, Thomas
    Braun, Thomas
    Eschenhagen, Thomas
    Zimmermann, Wolfram
    HUMAN GENE THERAPY, 2009, 20 (11) : 1395 - 1396
  • [23] The addition of human iPS cell-derived neural progenitors changes the contraction of human iPS cell-derived cardiac spheroids
    Mukae, Yosuke
    Itoh, Manabu
    Noguchi, Ryo
    Furukawa, Kojiro
    Arai, Ken-ichi
    Oyama, Jun-ichi
    Toda, Shuji
    Nakayama, Koichi
    Node, Koichi
    Morita, Shigeki
    TISSUE & CELL, 2018, 53 : 61 - 67
  • [24] Engineered human myocardium for enhanced maturation of pluripotent stem cell-derived cardiomyocytes
    Tiburcy, M.
    Liaw, N.
    Schlick, S.
    Zimmermann, W-H
    ACTA PHYSIOLOGICA, 2019, 227 : 17 - 17
  • [25] Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
    Rajamohan, Divya
    Kalra, Spandan
    Minh Duc Hoang
    George, Vinoj
    Staniforth, Andrew
    Russell, Hugh
    Yang, Xuebin
    Denning, Chris
    STEM CELLS AND DEVELOPMENT, 2016, 25 (06) : 439 - 452
  • [26] Genetically engineered cell-derived nanovesicles for cancer immunotherapy
    He, Shan
    Zhao, Zongmin
    NANOSCALE, 2024, 16 (17) : 8317 - 8334
  • [27] Drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
    Yamazaki, Daiju
    Kitaguchi, Takashi
    Ishimura, Masakazu
    Taniguchi, Tomohiko
    Yamanishi, Atsuhiro
    Saji, Daisuke
    Takahashi, Etsushi
    Oguchi, Masao
    Moriyama, Yuta
    Maeda, Sanae
    Miyamoto, Kaori
    Morimura, Kaoru
    Ohnaka, Hiroki
    Tashibu, Hiroyuki
    Sekino, Yuko
    Miyamoto, Norimasa
    Kanda, Yasunari
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 170 - 170
  • [28] Retention of locally injected human iPS cell-derived cardiomyocytes into the myocardium using hydrolyzed gelatin
    Iida, Jun
    Kotani, Kazuki
    Murata, Kozue
    Hakamada, Keisuke
    Maihemuti, Wusiman
    Mandai, Yoshinobu
    Hiraoka, Yosuke
    Minatoya, Kenji
    Masumoto, Hidetoshi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [29] Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts
    Yuji Shiba
    Toshihito Gomibuchi
    Tatsuichiro Seto
    Yuko Wada
    Hajime Ichimura
    Yuki Tanaka
    Tatsuki Ogasawara
    Kenji Okada
    Naoko Shiba
    Kengo Sakamoto
    Daisuke Ido
    Takashi Shiina
    Masamichi Ohkura
    Junichi Nakai
    Narumi Uno
    Yasuhiro Kazuki
    Mitsuo Oshimura
    Itsunari Minami
    Uichi Ikeda
    Nature, 2016, 538 : 388 - 391
  • [30] Molecular Characterization of Induced Pluripotent Stem (iPS) Cell-Derived Cardiomyocytes
    Ohno, Yohei
    Yuasa, Shinsuke
    Egashira, Toru
    Seki, Tomohisa
    Hashimoto, Hisayuki
    Toyama, Shugo
    Yoon, Sung Han
    Arai, Takahide
    Hao, Chen
    Tanaka, Tomofumi
    Hattori, Fumiyuki
    Yae, Kojiro
    Murata, Mitsushige
    Ogawa, Satoshi
    Yamanaka, Shinya
    Fukuda, Keiichi
    CIRCULATION, 2009, 120 (18) : S765 - S765
12345